Company Filing History:
Years Active: 1998-2004
Title: The Innovations of David Sackler
Introduction
David Sackler is an accomplished inventor based in Greenwich, CT (US). He has made significant contributions to the field of opioid formulations, focusing on bioavailable sustained release oral opioid analgesic dosage forms. With a total of 3 patents to his name, Sackler's work is pivotal in advancing pain management therapies.
Latest Patents
Sackler's latest patents include innovative melt-extruded orally administrable opioid formulations. These formulations comprise a plurality of multiparticulates produced via melt extrusion techniques. His work aims to enhance the bioavailability and sustained release of opioid analgesics, providing more effective pain relief options for patients.
Career Highlights
Throughout his career, Sackler has been associated with Euro-Celtique S.A., a company known for its focus on pharmaceutical innovations. His expertise in opioid formulations has positioned him as a key player in the development of advanced pain management solutions.
Collaborations
Sackler has collaborated with notable professionals in the field, including Benjamin Oshlack and Mark Chasin. These partnerships have contributed to the successful development of his patented formulations.
Conclusion
David Sackler's contributions to opioid formulations reflect his commitment to improving patient care through innovative solutions. His work continues to influence the pharmaceutical industry and enhance pain management therapies.